Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Case Report

Published on 04 Apr 2024

Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: a case report

in Cancer Molecular Targets and Therapeutics

Zhedong Zhang
Yu Huang
Haihua Gu
Lufeng Zhao
Baiqin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1370666

1,291 views
2 citations

Review

Published on 28 Mar 2024

Therapeutic prospects of nectin-4 in cancer: applications and value

in Cancer Molecular Targets and Therapeutics

Kaiyue Li
Yujing Zhou
Maolin Zang
Xin Jin
Xin Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1354543

10,253 views
5 citations

Original Research

Published on 25 Mar 2024

Pan-cancer and single-cell analyses identify CD44 as an immunotherapy response predictor and regulating macrophage polarization and tumor progression in colorectal cancer

in Cancer Molecular Targets and Therapeutics

Qian Zhang
Xinyu Wang
Yang Liu
Hao Xu
Chun Ye

Frontiers in Oncology

doi 10.3389/fonc.2024.1380821

3,544 views
2 citations

Retraction

Published on 20 Mar 2024

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2024.1399853

757 views

Original Research

Published on 14 Mar 2024

DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis

in Cancer Molecular Targets and Therapeutics

Shiyu Cao
Xinyi Long
Lin Xiao
Peichuan Zhang
Mengjia Shen
Fei Chen
Chunjuan Bao
Xiaorong Zhong
Ting Luo
Feng Ye

Frontiers in Oncology

doi 10.3389/fonc.2024.1356778

2,173 views
1 citation

Case Report

Published on 14 Mar 2024

Case report: Targeted treatment strategies for Erdheim-Chester disease

in Cancer Molecular Targets and Therapeutics

Anita Gulyás
László Imre Pinczés
János Mátyus
Edit Végh
Judit Bedekovics
Judit Tóth
Sándor Barna
Zsolt Hunya
Imre Lőrinc Szabó
Annamária Gazdag

Frontiers in Oncology

doi 10.3389/fonc.2024.1305518

2,020 views

Case Report

Published on 11 Mar 2024

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

in Cancer Molecular Targets and Therapeutics

Loc Carlo Bao
Alessia Padovan
Andrea Boscolo Bragadin
Lorenzo Calvetti
Valentina Guarneri
Laura Bonanno
Stefano Indraccolo

Frontiers in Oncology

doi 10.3389/fonc.2024.1363069

1,827 views

Review

Published on 08 Mar 2024

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer

in Cancer Molecular Targets and Therapeutics

Linxiang Zhang
Xueying Zhang
Yan Shi
Yuhan Ni
Jiaojiao Fei
Zhixin Jin
Wenjuan Li
Xiaojing Wang
Nan Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1376916

1,940 views
3 citations

Mini Review

Published on 07 Mar 2024

Experimental evidence for anti-metastatic actions of apigenin: a mini review

in Cancer Molecular Targets and Therapeutics

Hyeon-Muk Oh
Chong-Kwan Cho
Nam-Hun Lee
Chang-Gue Son

Frontiers in Oncology

doi 10.3389/fonc.2024.1380194

1,548 views

Original Research

Published on 07 Mar 2024

Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis

in Cancer Molecular Targets and Therapeutics

Fangxi Zhang
Xiaofeng Wan
Jianmin Zhan
Ming Shen
Runsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1361152

2,031 views
1 citation

Review

Published on 06 Mar 2024

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Qian Xu
Caiyan Jia
Yan Ou
Chuanxiu Zeng
Yingjie Jia

Frontiers in Oncology

doi 10.3389/fonc.2024.1371421

6,984 views
1 citation

Mini Review

Published on 04 Mar 2024

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Rachel R. Tindall
Jennifer M. Bailey-Lundberg
Yanna Cao
Tien C. Ko

Frontiers in Oncology

doi 10.3389/fonc.2024.1362247

3,133 views
2 citations

Correction

Published on 29 Feb 2024

Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3

in Cancer Molecular Targets and Therapeutics

Halima Alsamri
Hussain El Hasasna
Yusra Al Dhaheri
Ali H. Eid
Samir Attoub
Rabah Iratni

Frontiers in Oncology

doi 10.3389/fonc.2023.1235201

1,114 views

Review

Published on 28 Feb 2024

Expression and prognosis of ADAMTS18 in different tumors

in Cancer Molecular Targets and Therapeutics

Wenfei Guo
Yuying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1347633

1,369 views

Editorial

Published on 28 Feb 2024

Editorial: Integrating transcriptional modulation in systemic tumor therapy

in Cancer Molecular Targets and Therapeutics

Daniel Heudobler
Florian Lüke
Lina Ghibelli
Albrecht Reichle

Frontiers in Oncology

doi 10.3389/fonc.2024.1385766

825 views

Systematic Review

Published on 28 Feb 2024

A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals

in Cancer Molecular Targets and Therapeutics

D. Robert Paval
Thomas G. Di Virgilio
Richard J. E. Skipworth
Iain J. Gallagher

Frontiers in Oncology

doi 10.3389/fonc.2024.1198555

1,443 views

Navigation group

Articles

Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: a case report

Therapeutic prospects of nectin-4 in cancer: applications and value

Pan-cancer and single-cell analyses identify CD44 as an immunotherapy response predictor and regulating macrophage polarization and tumor progression in colorectal cancer

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis

Case report: Targeted treatment strategies for Erdheim-Chester disease

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer

Experimental evidence for anti-metastatic actions of apigenin: a mini review

Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3

Expression and prognosis of ADAMTS18 in different tumors

Editorial: Integrating transcriptional modulation in systemic tumor therapy

A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals